• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

California Physician Practices to Use Apple Watches to Advance Physician-Patient Communication

Share:

October 16, 2019

– Healthcare services company for physicians Altais partners with Notable Health to use intelligent automation to enhance the patient experience.

– Notable Health’s A.I.-driven platform uses Apple Watches and smartphone devices to advance physician-patient communications and streamline administrative tasks.

– Notable’s AI-powered platform is a game-changer for clinicians previously spending hours on redundant administrative tasks. The platform—which seamlessly integrates with legacy EHR systems—acts as a smart, virtual workforce, giving access to more real-time data while streamlining efficiencies.

Altais, a healthcare services company that helps physicians and the clinical community in collaboration with Blue Shield of California, today announced a partnership with Notable Health to use intelligent automation to enhance the patient experience and automate administrative workflows for physician practices. Together, the parties are collaborating to leverage Notable’s technology to bring workflow innovation to physicians, beginning with Blue Shield of California’s network physician partners.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Better Data Collection and Transfer Via Notable’s AI-Powered Platform

Notable’s technology reduces administrative overhead and enriches patient-clinician interactions through better data collection and transfer. Patients using the platform will benefit from a streamlined check-in process using their smartphone—starting with appointment reminders and insurance eligibility checks to self-assessment health surveys that can be pre-populated within a patient’s chart.

Using Apple Watch to Advance Physician-Patient Communication

During the visit, doctors no longer must type in reams of content to the electronic health record (EHR). Instead, they will use Notable’s wearable technology supported by an Apple Watch, to document physician-patient discussions. The technology uses machine learning and natural language processing to parse the conversation down to its relevant pieces and accurately insert facts onto the patient’s electronic file. Post-visit, the artificial intelligence (AI)-powered technology optimizes charting efficiency by ensuring the proper entry of orders and procedures to generate clean claims.

For example, doctors at the Paradise Medical Group (PMG) in Paradise, Calif. will soon begin using the Apple Watches and Notable technology to support patients’ visits. PMG is the first Blue Shield partner to use the services, which are now available to network physicians.

“Deploying our technology will improve data quality and help Blue Shield of California partners spend less time documenting care and more time delivering care,” said Pranay Kapadia, CEO, and co-founder of Notable Health. “We know that better data empowers better outcomes, and we’re bridging the data divide between patients, their physicians, and payers.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • NHS Wales Launches ‘Caring’ AI Virtual Agent Using IBM WatsonNHS Wales Launches ‘Caring’ AI Virtual Agent Using IBM Watson
  • Oncomatryx Acquires Tube Pharmaceuticals GmbH to Consolidate its Pioneering Pipeline of ADCs Targeting the Tumor MicroenvironmentOncomatryx Acquires Tube Pharmaceuticals GmbH to Consolidate its Pioneering Pipeline of ADCs Targeting the Tumor Microenvironment
  • Sagard Healthcare Royalty Partners and Newcastle University, UK Announce the Monetization of Royalty Interest in Cancer Drug, RubracaSagard Healthcare Royalty Partners and Newcastle University, UK Announce the Monetization of Royalty Interest in Cancer Drug, Rubraca
  • Surescripts and Diameter Health Partner to Enhance Clinical IntelligenceSurescripts and Diameter Health Partner to Enhance Clinical Intelligence
  • Remodel Health & PeopleKeep | Transforming SMB Health BenefitsRemodel Health & PeopleKeep | Transforming SMB Health Benefits
  • CityMD Expands to Ocean County with Acquisition of Urgent Care NowCityMD Expands to Ocean County with Acquisition of Urgent Care Now
  • AI Technology Detects ‘Ticking Time Bomb’ ArteriesAI Technology Detects ‘Ticking Time Bomb’ Arteries
  • BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications